ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,214.50
-0.10%
S&P ASX All Technology
3,562.20
0.19%
Brent Oil
78.695
-0.46%
US Dollar vs AUD
1.48126
-0.17%
Bitcoin
62,949.34
4.44%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Applied Therapeutics Inc (APLT) Share Price

Applied Therapeutics Inc

Applied Therapeutics Inc (APLT)

NASDAQ
8.57
0.37
(4.51%)
At close: 12 October 7:00AM
Delayed by 15 minutes
8.5016
-0.0684
( -0.80% )
After Hours: 7:58AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
8.5016
Bid
8.50
Offer
8.55
Volume
1,325,452
8.03 Day's Range 8.68
1.79 52 Week Range 9.39
Market Cap
976.377M
Previous Close
8.20
Open
8.20
Last Trade
30
@
8.5
Last Trade Time
07:54:58
Financial Volume
US$ 11,068,863
VWAP
8.351
Average Volume (3m)
2,494,584
Shares Outstanding
114,846,271
Dividend Yield
-
PE Ratio
-8.21
Earnings Per Share (EPS)
-1.04
Revenue
9.99M
Net Profit
-119.76M

About Applied Therapeutics Inc

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.appliedtherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Applied Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APLT. The last closing price for Applied Therapeutics was US$8.20. Over the last year, Applied Therapeutics shares have traded in a share price range of US$ 1.79 to US$ 9.39.

Applied Therapeutics currently has 114,846,271 shares in issue. The market capitalisation of Applied Therapeutics is US$941.74 million. Applied Therapeutics has a price to earnings ratio (PE ratio) of -8.21.

Ask ADVFN Intelligence (AI)

APLT Latest News

More News

Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia

- Company completed Late-Cycle review meeting with FDA - FDA no longer intends to hold Advisory Committee meeting - FDA Review of NDA continues to proceed as planned with PDUFA target action...

18 September 2024
GlobeNewswire Inc.

Applied Therapeutics to Participate in Upcoming Investor Conferences

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...

04 September 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

24 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 August 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

15 August 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

15 August 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

10 August 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 August 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 August 2024
Edgar (US Regulatory)

Applied Therapeutics Reports Second Quarter 2024 Financial Results

NDA and MAA for govorestat for treatment of Classic Galactosemia under FDA Priority Review and EMA review; PDUFA target action date of November 28, 2024, and EMA decision expected in early Q1...

07 August 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.50166.2788.577.5714315258.04273215CS
43.581672.79674796754.928.94.5552178037.8308027CS
123.196660.25636192275.3058.94.5524945847.24154632CS
262.961653.45848375455.548.93.9516964546.43760196CS
526.2016269.6347826092.39.391.7916556445.34097462CS
156-8.3784-49.6350710916.8819.140.49958014174.31791219CS
260-1.8384-17.779497098610.3457.390.49955380937.12919356CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
US$ 1.02
(168.70%)
21.08M
XPONExpion360 Inc
US$ 2.97
(24.27%)
886.31k
CELUCelularity Inc
US$ 3.03
(20.72%)
621
PETZTDH Holdings Inc
US$ 1.40
(12.00%)
2k
MDIAMediaco Holding Inc
US$ 1.29
(11.21%)
15.63k
ZPTAZapata Computing Holdings Inc
US$ 0.0948
(-63.68%)
1M
TWGTop Wealth Group Holding Ltd
US$ 5.40
(-24.37%)
3.71M
DWTXDogwood Therapeutics Inc
US$ 3.32
(-19.42%)
30.2k
MTEMMolecular Templates Inc
US$ 1.21
(-17.69%)
10.87k
IBGInnovation Beverage Group Limited
US$ 0.8598
(-14.02%)
162.85k
TVGNTevogen Bio Holdings Inc
US$ 1.02
(168.70%)
21.08M
JTAIJet AI Inc
US$ 0.094
(-6.93%)
5.28M
TWGTop Wealth Group Holding Ltd
US$ 5.40
(-24.37%)
3.71M
NVDANVIDIA Corporation
US$ 134.57
(-0.17%)
2.26M
CDTConduit Pharmaceuticals Inc
US$ 0.1077
(-7.47%)
1.92M

APLT Discussion

View Posts
morokoy morokoy 2 weeks ago
Option trade today 1/17/25, $12.50 @1,000
👍️0
morokoy morokoy 2 weeks ago
Option trade today 1/17/25, $12.50 @1,000
👍️0
Invest-in-America Invest-in-America 3 weeks ago
APLT: 200%-up, for sure today.
👍️0
Awl416 Awl416 3 weeks ago
Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
👍️0
Monksdream Monksdream 1 month ago
APLT under $7
👍️0
Monksdream Monksdream 5 months ago
APLT under $5
👍️0
InvestorPhilia4 InvestorPhilia4 7 months ago
I have held this for several years and there are many prospects progressing. I like the significant CEO ownership position.
👍️0
Monksdream Monksdream 7 months ago
APLT new 52 week high
👍️0
Monksdream Monksdream 7 months ago
APLT new 52 week high
👍️0
ddt60 ddt60 7 months ago
Outstanding
👍️0
Awl416 Awl416 7 months ago
Applied Therapeutics Announces $100 Million Private Placement
👍️0
Nadendla Nadendla 8 months ago
OMG.. really..
👍️0
Nadendla Nadendla 8 months ago
yup.. my mistake that i overlooked you.. you will financial crisis for the next 3 years..
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
APLT what a beast and not one ihubber talking. The best kind!
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
APLT...NEXT MONSTER BIO BEAST!!!
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
APLT...HUGE BREAK OUT PLAY
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT..THE NEXT BIO BEAST THAT WILL BEAST THROUGH BEASTVILLE
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT...4.47 HERE WE COME
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT...ANOTHER MONSTER IN THE MAKING
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT..HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT STRONG TREND IN PLACE
👍️0
ddt60 ddt60 9 months ago
Maybe this could run back up to where it was 4 years ago.
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT READY TO BLOW UP ONCE AGAIN
👍️0
stock1ace1 stock1ace1 9 months ago
Aplt $3.10 pending news
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
back in on break out
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT...THE MONSTER IS RUNNING HARD NOW
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT..HERES THE BREAK OUT...WEEKLY TRAND IN PLACE LIKE YOU HAVE NEVER SEEN
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT HAS THE BEST WEEKLY CHART OF ANY BIO OUT THERE
👍️0
halbroke1 halbroke1 1 year ago
Trend $$$ Great Pick with APLT $$$, I agree 100% here... Could easily Go To $10.00+ or Higher....EOD & After_Hours could get Wild..
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
wowza...look at her go
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT...READY FOR 2.67...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT MONSTER IN THE MAKING...WEEKLY BLOW OUT TREND IN PLACE
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT BIO BEAST READY TO BEAST
👍️0
81vette 81vette 1 year ago
took the news a few days to sink in,no date yet on fda meeting(says,this summer smh) ema marketing application in fall for other drug,update is good,just a bit more time
👍️0
tw0122 tw0122 1 year ago
Up up some
👍️0
81vette 81vette 2 years ago
Buy rating $23-$29 Citigroup,the Barclays $7-$9 is more believable,omg the greed will be strong,any hint of fda news like fast track will make heads explode lol
👍️0
81vette 81vette 2 years ago
Pps above 200ma,golden cross coming ,greatest long chart indicator ever,macd about to cross bullish line,short algos wouldn’t touch a ticker like this and shorts gotta cover! Lions tigers and bulls OHHH MYYY!!!
👍️0
81vette 81vette 2 years ago
Look at what happens with green vol on 1 year chart below,high reward/no risk in past,that’s amazing!!! Every time up !!
👍️0
81vette 81vette 2 years ago
Trading natural/no naked shorting atm
👍️0
81vette 81vette 2 years ago
Pre mkt today$1.40ish/$1.25ave,tonight and tomorrow continues up as word spreads and scanners blowing up
👍️0
81vette 81vette 2 years ago
Looking good for week long run like in past with near record volume
👍️0

Your Recent History

NASDAQ
APLT
Applied Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved